361.8500 1.85 (0.51%)
NSE Mar 17, 2026 15:02 PM
Volume: 108.9K
 

361.85
0.51%
Prabhudas Lilladhar
and 3) increased employee cost at 16% of sales (v/s 11% YoY and 13% QoQ). EBIT margin for diagnostic segment was 9% v/s 42% YoY. its profitability because of 1) lower gross margin at 53% (v/s 72% YoY) due to We remain negative on entire diagnostic chain due to possible structural...
Institutional Investors have increased holdings from 18.32% to 25.48% in Dec 2025 qtr.
More from Thyrocare Technologies Ltd.
Recommended